MISC-IPV: a Community-Based Intervention for Children Traumatized by Intimate Partner Violence
Launched by UNIVERSITY OF HOUSTON · Jul 6, 2023
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
The MISC-IPV trial is studying a new program called the Mediational Intervention for Sensitizing Caregivers (MISC), designed to help women and children of color who have experienced domestic violence. This trial aims to see how effective this intervention is in supporting children aged 7 to 11 who have been exposed to intimate partner violence. The program also includes their mothers, who must be enrolled in a domestic violence rehousing program and speak English.
To participate, mothers should not have severe mental health issues, and children must be within the specified age range and not have certain developmental disorders. Those who qualify will receive support aimed at improving their well-being after experiencing trauma. If you or someone you know might fit this description and is interested in participating, it’s a great opportunity to receive help while contributing to important research.
Gender
ALL
Eligibility criteria
- Mother inclusion criteria:
- • 1. Enrolled in Harris County Domestic Violence rehousing program
- • 2. Fluency in English
- Mother exclusion criteria:
- • 1. Active suicidality
- • 2. Intellectual disability
- • 3. Active psychotic disorder
- Child inclusion criteria:
- • 1. Exposure to domestic violence
- • 2. 7-11 years old in a family
- Child exclusion criteria:
- • 1. Intelligence quotient below 75,
- • 2. Active psychosis
- • 3. Severe autism
- • 4. Below age 7 or above age 11
About University Of Houston
The University of Houston is a leading research institution dedicated to advancing knowledge and innovation across various disciplines, including clinical research. With a commitment to enhancing public health and well-being, the university actively sponsors clinical trials that explore new treatments and interventions. Leveraging its robust academic resources and expertise, the University of Houston fosters collaboration among researchers, healthcare professionals, and community partners to address pressing health challenges and contribute valuable insights to the medical field. Through its clinical trial initiatives, the university aims to translate research findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Carla Sharp
Principal Investigator
csharp2@uh.edu
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported